Article

Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity

2023-01-05

Abstract excerpt

<title>Abstract</title> <p>Triple negative breast cancer (TNBC) is a most aggressive type of breast cancer without effective therapies. Cyclodextrin, a cyclic oligosaccharide is used as drug delivery carrier with cholesterol lowering property. However, whether cyclodextrin can inhibit the proliferation and migration of TNBC as well as the underlying mechanisms are unclear. In the present study, we demonstrated th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 34933e6b-71b9-58c7-a492-542ebc4e7d8b
DOI: 10.21203/rs.3.rs-2392210/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunityDOI 10.21203/rs.3.rs-2392210/v1Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read

Eribulin represses effector T cell differentiation and enhances T cell-mediated anti-tumor activity to triple negative breast cancer cells through the facilitation of CD8+ T cell proliferationSemantic proximity Read

Triple Negative Breast Cancer Treatment Options and Limitations: Future OutlookSemantic proximity Read

Toll Like Receptor 4 and IFNγ Signalling axis as a therapeutic target in Triple negative Breast CancerSemantic proximity Read

Toll-Like Receptor 2 Promotes Breast Cancer Progression and Resistance to ChemotherapySemantic proximity Read

Targeting claudin-4 enhances chemosensitivity of triple negative breast cancerSemantic proximity Read

Glycosylated extracellular matrix drives immune suppression by controlling T cell movement, macrophage phenotype, and macrophage-T cell crosstalk in triple negative breast cancerSemantic proximity Read

Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapySemantic proximity Read

Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysisSemantic proximity Read

Temporal Changes in Immune Responses within the Tumor Microenvironment in the 4T1.2-HER2 Mammary Tumor ModelSemantic proximity Read

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.Semantic proximity Read

Transdermal nanolipoplex simultaneously inhibits subcutaneous melanoma growth and suppresses systemically metastatic melanoma by activating host immunitySemantic proximity Read